65 related articles for article (PubMed ID: 38021093)
21. Risk factors for the long-term persistent genitourinary toxicity after stereotactic body radiation therapy for localized prostate cancer: A single-center, retrospective study of 306 patients.
Tanabe K; Kobayashi S; Tamiya T; Konishi T; Hinoto R; Tsukamoto N; Kashiyama S; Eriguchi T; Noro A
Int J Urol; 2024 Jun; ():. PubMed ID: 38822642
[TBL] [Abstract][Full Text] [Related]
22. The Status and Challenges for Prostate Stereotactic Body Radiation Therapy Treatments in United States Proton Therapy Centers: An NRG Oncology Practice Survey.
Shen J; Taylor PA; Vargas CE; Kang M; Saini J; Zhou J; Wang P; Liu W; Simone CB; Xiao Y; Lin L
Int J Part Ther; 2024 Mar; 11():100020. PubMed ID: 38757080
[TBL] [Abstract][Full Text] [Related]
23. Local coverage determination policy and the use of stereotactic body radiation therapy for prostate cancer.
Jacobs BL; Sunderland R; Yabes J; Nelson JB; Barnato AE; Bekelman JE
Urol Pract; 2015 Nov; 2(6):304-311. PubMed ID: 27493987
[TBL] [Abstract][Full Text] [Related]
24. Adaptive Proton Therapy Using CBCT-Guided Digital Twins.
Chang CW; Tian Z; Qiu RLJ; McGinnis HS; Bohannon D; Patel P; Wang Y; Yu DS; Patel SA; Zhou J; Yang X
ArXiv; 2024 May; ():. PubMed ID: 38800650
[TBL] [Abstract][Full Text] [Related]
25. An in-silico planning study of stereotactic body radiation therapy for polymetastatic patients with more than ten extra-cranial lesions.
Iori F; Torelli N; Unkelbach J; Tanadini-Lang S; Christ SM; Guckenberger M
Phys Imaging Radiat Oncol; 2024 Apr; 30():100567. PubMed ID: 38516028
[TBL] [Abstract][Full Text] [Related]
26. Exploration of clinical preferences in treatment planning of radiotherapy for prostate cancer using Pareto fronts and clinical grading analysis.
Kyroudi A; Petersson K; Ozsahin E; Bourhis J; Bochud F; Moeckli R
Phys Imaging Radiat Oncol; 2020 Apr; 14():82-86. PubMed ID: 33458319
[TBL] [Abstract][Full Text] [Related]
27. Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas.
Tchelebi LT; Segovia D; Smith K; Shi Q; Fitzgerald TJ; Chuong MD; Zemla TJ; O'Reilly EM; Meyerhardt JA; Koay EJ; Lowenstein J; Shergill A; Katz MHG; Herman JM
Int J Radiat Oncol Biol Phys; 2024 Mar; ():. PubMed ID: 38492812
[TBL] [Abstract][Full Text] [Related]
28. Predicting radiation-induced immune suppression in lung cancer patients treated with stereotactic body radiation therapy.
Colen J; Nguyen C; Liyanage SW; Aliotta E; Chen J; Alonso C; Romano K; Peach S; Showalter T; Read P; Larner J; Wijesooriya K
Med Phys; 2024 Jun; ():. PubMed ID: 38837261
[TBL] [Abstract][Full Text] [Related]
29. Clinical Impact of Contouring Variability for Prostate Cancer Tumor Boost.
Zhong AY; Lui AJ; Kuznetsova S; Kallis K; Conlin C; Do DD; Domingo MR; Manger R; Hua P; Karunamuni R; Kuperman J; Dale AM; Rakow-Penner R; Hahn ME; van der Heide UA; Ray X; Seibert TM
Int J Radiat Oncol Biol Phys; 2024 Jun; ():. PubMed ID: 38925224
[TBL] [Abstract][Full Text] [Related]
30. Implementing a Novel Remote Physician Treatment Coverage Practice for Adaptive Radiation Therapy During the Coronavirus Pandemic.
Price A; Kim H; Henke LE; Knutson NC; Spraker MB; Michalski J; Hugo GD; Robinson CG; Green O
Adv Radiat Oncol; 2020; 5(4):737-742. PubMed ID: 32775784
[TBL] [Abstract][Full Text] [Related]
31. DIVE-ART: A tool to guide clinicians towards dosimetrically informed volume editions of automatically segmented volumes in adaptive radiation therapy.
Roberfroid B; Lee JA; Geets X; Sterpin E; Barragán-Montero AM
Radiother Oncol; 2024 Mar; 192():110108. PubMed ID: 38272315
[No Abstract] [Full Text] [Related]
32. Predictors of radiation-induced late rectal toxicity in prostate cancer treatment: a volumetric and dosimetric analysis.
Spohn SKB; Radicioni G; Eisfelder M; Zamboglou C; Baltas D; Grosu AL; Sachpazidis I
Front Oncol; 2024; 14():1371384. PubMed ID: 38737910
[TBL] [Abstract][Full Text] [Related]
33. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.
Fink CA; Buchele C; Baumann L; Liermann J; Hoegen P; Ristau J; Regnery S; Sandrini E; König L; Rippke C; Bonekamp D; Schlemmer HP; Debus J; Koerber SA; Klüter S; Hörner-Rieber J
Front Oncol; 2024; 14():1308406. PubMed ID: 38425342
[TBL] [Abstract][Full Text] [Related]
35. Full automation of spinal stereotactic radiosurgery and stereotactic body radiation therapy treatment planning using Varian Eclipse scripting.
Teruel JR; Malin M; Liu EK; McCarthy A; Hu K; Cooper BT; Sulman EP; Silverman JS; Barbee D
J Appl Clin Med Phys; 2020 Oct; 21(10):122-131. PubMed ID: 32965754
[TBL] [Abstract][Full Text] [Related]
36. Proton therapy- the modality of choice for future radiation therapy management of Prostate Cancer?
Mangan S; Leech M
Tech Innov Patient Support Radiat Oncol; 2019 Sep; 11():1-13. PubMed ID: 32095544
[TBL] [Abstract][Full Text] [Related]
37. Adaptive radiotherapy for breast cancer.
De-Colle C; Kirby A; Russell N; Shaitelman SF; Currey A; Donovan E; Hahn E; Han K; Anandadas CN; Mahmood F; Lorenzen EL; van den Bongard D; Groot Koerkamp ML; Houweling AC; Nachbar M; Thorwarth D; Zips D
Clin Transl Radiat Oncol; 2023 Mar; 39():100564. PubMed ID: 36632056
[TBL] [Abstract][Full Text] [Related]
38. CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer.
Waters M; Price A; Laugeman E; Henke L; Hugo G; Stowe H; Andruska N; Brenneman R; Hao Y; Green O; Robinson C; Gay H; Michalski J; Baumann BC
Clin Transl Radiat Oncol; 2024 Jan; 44():100693. PubMed ID: 38021093
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
